Navigation Links
European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA)
Date:9/9/2011

BRUSSELS, September 9, 2011 /PRNewswire/ --

The Board of the European Fine Chemicals Group (EFCG) is delighted to announce that today it agreed to ratify the proposal of the US Food and Drug Administration (FDA) to put forward a legislative package, designed with the help of EFCG and US industry representatives, to deliver into US law a new Generic Drug User Fees Act (GDUFA).

GDUFA requires the FDA to commit to significantly improve and enhance its regulatory activities for the benefit of global generic drug providers and US generic drug users, in exchange for the global generics industry providing FDA with $299 million in user fees each year over the next 5 years.

The key benefits for drug providers will be faster and more predictable regulatory review times, including dealing with the backlog of applications, and parity of inspections between domestic and foreign sites for both finished dosage form (FDF) and active pharmaceutical ingredient (API) manufacturers.

Guy Villax, CEO of Hovione and an EFCG Board member, who led the EFCG negotiating team, commented "the outcome of these negotiations are epoch-making for our industry and, if adopted, will go a long way to deliver on EFCG's major objective to level the playing field for its members. Regulators' weak enforcement has made non-compliance a major competitive advantage. We congratulate FDA for leading the way to find solutions that both protect the patient and stop unfair competition."

Notes for editors:

Generic drugs are those containing off-patent APIs made available to patients via a doctor's prescription. Over the counter (OTC) drugs available to patients without prescription are excluded from GDUFA.

For public minutes of industry meetings with the FDA see the FDA website at

http://www.fda.gov/ForIndustry/UserFees/GenericDrugUserFees/ucm256662.htm

The European Fine Chemicals Group was formed in 2004 as a sector group of the Brussels-based European Chemical Industry Council (Cefic) and represents fine chemical manufacturers in Europe, including those who make generic APIs. See http://www.efcg.cefic.org

 

For further information, contact Tony Scott, Adviser to EFCG on tscott@tsassoc.eu , +44-1428-641-168


 


'/>"/>
SOURCE Environmental Financial Consulting Group (EFCG)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
6. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
9. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
10. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
11. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE), ... low molecular weight fraction of human serum albumin ... re-issuing its previous release that was made on March ... required under the NYSE MKT Company Guide Sections ... along with the previously disclosed update of corporate ...
(Date:3/22/2017)...  ImaginAb Inc. today announced the appointment of Martyn Coombs ... , chairman of ImaginAb, said "At ImaginAb we have exciting science ... relevant to our business, particularly in commercializing and making step changes ... we can realize our potential." ... Mr. Coombs is a recognized industry leader in nuclear ...
(Date:3/22/2017)... , 22. März 2017   ... und weltweit tätige Anbieter von Produkten und ... den Erwerb von EPL Archives Inc. bekannt, ... der Kunden im kompletten Zyklus regulierter Forschung, ... von Proben, Speicherung von Dokumenten und Zusatzdienstleistungen ...
Breaking Medicine Technology:
(Date:3/23/2017)... , ... March 23, 2017 , ... It’s that time ... many students are thinking about summer internships , which can be frustrating when ... The pros at Garden Media Group, a boutique public relations firm outside of Philadelphia, ...
(Date:3/23/2017)... Chatham, New Jersey (PRWEB) , ... March 23, ... ... a developer of herbal-based and non-steroidal skincare products, was awarded as winners of ... with innovation products. This competition was hosted jointly by HSN and Good Housekeeping. ...
(Date:3/23/2017)... ... ... News Advisory/Interview Opportunity , After six years of advocacy, testimony and grassroots organizing, ... health and the environment and is calling on the United States to follow the ... of European citizens, the European Union (EU) will, beginning next year, ban the use ...
(Date:3/23/2017)... ... ... “A Respectful Response To Atheist Manifesto”: theological refutation of ... the creation of published author Richard Hostetter, a former missionary in Africa who ... degrees from Kent State University and the University of Ghana. , Published by ...
(Date:3/22/2017)... CA (PRWEB) , ... March 22, 2017 , ... ... community, announces the publication of the first issue of its companion print magazine. ... the public about cosmetic surgery thanks to information provided by board-certified doctors from ...
Breaking Medicine News(10 mins):